IL‐17f, an IL‐17a heterodimer partner, is a prime mediator of colitis (Tang et al, 2018), and we showed a significant reduction in this cytokine expression levels in FKK6‐treated mice compared to vehicle‐treated mice (Fig 5F). The gene discussed is IL17F; the disease is colitis.